Moe Alsumidaie


Breaking New Ground in Cardiovascular Health: Innovative Approaches in Clinical Trial Design

May 22, 2023

In this Q&A, John Kastelein, MD, founder and chief scientific officer, NewAmsterdam Pharma, discusses the challenges and opportunities within the cardiovascular field, exploring the current landscape for lipid-lowering therapies and the unique potential advantages of CETP inhibitors.

Why Did CVS Shutter its Clinical Trials Unit?

May 17, 2023

The journey of CVS Health’s clinical trials unit serves as a speculative case study, reminding us that venturing into new market areas, even for established companies, necessitates a careful evaluation of strategic fit, competition, infrastructure, financial constraints, and industry trends.